chrisvoncsefalvay/vaers-outcomes huggingface dataset:
THE DAY AFTER CLIENT RECIEVED INJECTION SHE BROKE OUT IN HIVES ALL OVER HER BODY - LASTED 3 WEEKS. NEXT DAY HER LIPS BECAME SWOLLEN. THE DAY AFTER THAT HER HANDS AND FEET STARTED TINGLING AND FELT NUMB. CLIENT WAS SEEN AT AN URGENT CARE ER - GIVEN STEROIDS AND CLARITIN. ALL SYMPTOMS HAVE RESOLVED.
Severe HA that began on right side with tightening of the right jaw.  Started at 0200 1/1/21.  Lasted for more than 48 hours.  Then went away. Returned 2 days after that for 4 days.   Then went away for 2 days then  returned for 1 day.  Then came back say 1/17/21  and has persisted through today.    Accompanied by dizziness at various times not with ha
having severe arm pain since her first dose and the pain "has not stopped"; pain affects her ability to take off the seatbelt and take off her shirt; arm pain/It went from shoulder down to elbow; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 52-years-old female patient reported for herself that she received first dose of bnt162b2 (COMIRNATY, Solution for injection, Lot Number: FF2587), via an unspecified route of administration on 13Sep2021 (age at vaccination was 52 years) as dose 1, single and second dose of bnt162b2 (Lot Number: FF2589), via an unspecified route of administration on 04Oct2021 (age at vaccination was 52 years) as dose 2, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had reaction to the Covid-vaccine. Patient complained that she does not take vaccines and had got covid vaccine because that was a mandate and she was forced for it. She got that on the last possible date to get the vaccine. On an unspecified date in Sep2021, the patient was having severe arm pain since her first dose and the pain had not stopped. The patient reported that the pain affected her ability to take off the seatbelt and take off her shirt. Patient stated that it had been constant since first shot. It went from shoulder down to elbow. It did hurt when she moved. This report was non-serious. Investigation assessment was not reported.   The outcome of the event pain in arm was not recovered while other events was unknown.
2nd dose administered before the 2-6 month period; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   In October 2022, the patient received the 2nd dose of Shingrix. In October 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.     Additional Information: GSK Receipt Date: 24-Oct-2022 Reporter's comment: Inquiry came in via chat. On 3rd October 2022, the patient received first dose of Shingrix. The pharmacist had a question on the administration of the Shingrix vaccine. The second dose was administered before the 2 and 6 month period that would the patient have to retake the second dose. The reporter did not consent to follow-up.  User ended chat before providing any details. Additional supportive information: The patient received 2nd dose of Shingrix, earlier than the recommended interval, which led to shortening of vaccinations schedule.
Headache, Myalgia, Arthralgia, Fever, fatigue, chills. Narrative: had to leave work due to s/s of chills, musc and joint aches, headaches, fatigue. she feels her GI may soon also be involved.
White conical cyst [lesion] on right side of back of tongue 7 days after first injection. Some bleeding occurred and subsided an hour later. Seen by PA at Urgent Care on 04/19/2021. Presribed Ammoxicillan 500mg 1 per day x 15 days and Lidocaine Viscous  2% solution, 3xday. 2nd Covid19 Moderna shot administered 05/10/2021 at 11 AM. 2nd cyst [lesion] appeared and was larger (size of a pea) on 05/13/2021. Some occasional bleeding occurred. Began gargling with baking soda and salt 3-4 times a day and Tylenol, 1-2 times a day. Was seen by Dr. on 05/18/2021 at 1:40 PM. No procedures perfored at time of appointment. Referred me to another ENT doctor. Since I do not have health insurance, I've been challenged with proceeding with further consultations, treatments, etc. Continuing gargling with baking soda and salt water 3-4 times a day, Tylenol 1-2 times a day and Claritin 1 per day for seasonal allergies. Stopped drinking alcholic beverages. Also researching doctors who may accept self-pay, etc.
Fever or Chills  Muscle or body aches  Headache  Sore throat
On 31 Aug 2021 after aprox 24 hours of the first Covid-19 vaccine dose, an unexpected postmenopausal  vaginal blessing started and after two days it became heavier and I went to Emergency  Room on 02 Sep2021. (Note: My last menstrual cycle was two years ago). Laboratory tests and  Ultrasounds (Pelvis Limited Transabdominal and Pelvis Trasvaginal) were completed. No assignable  caused were identified for the postmenopausal dysfunctional uterine bleeding and Dr. prescribed  (Norethindone) to stop the bleeding. I started the treatment on 03 Sep2021 and the bleeding basically  stop after 2 days of treatment. I completed the treatment as required. I sent all results to my  gynecologist  On 20 Sep2021, I received the 2nd doses of Covid 19 Pfizer vaccine (Lot # FF2588) on my left arm. This vaccination occurred in the same location as the previous one. On 21Sep2021, I had a headache and at night I had fever (100F). On 22 Sep2021, an unexpected postmenopausal bleeding started again.   I appreciate your further evaluation of the effect of this vaccine in post menopaused woman. Let me know if additional information is required. You can contact me or my gynecologist for additional information.
Rash noticed within an hour around injection site, on torso, back of neck and in diaper area. Slimy loose stool 6 hours later with increased crying/irritability. Fever noted by temporal thermometer at ER.
This spontaneous report was received from a pharmacist refers to a 79 years old female with hypercholesterolemia and hypertension and no drugs reactions or allergies, who on 24-DEC-2012, was vaccinated subcutaneously with 0.65 ml dose of live ZOSTAVAX (lot number H012523, Exp. Date:09-OCT-2013. No other co-suspects were reported, No concomitant medications were reported. It was reported that on 24-DEC-2012, the patient developed a red area around injection site about a size of quarter, 1 day after onset of therapy and patient developed a red area around injection site about a size of quarter which was mildly itchy. No treatment was given for the experience. No lab diagnostics studies were performed. At the time of the report, the itching has subsided, but the redness was still present. The patient sought unspecified medical attention. The relatedness for patient developed a red area around injection site about a size of quarter which was mild itchy was unknown for live ZOSTAVAX. Additional information has been requested.
Pt grew pale and passed out 3-5 minutes after receiving the vaccine.  Mostly recovered about 15 minutes later.
Information has been received from a physician concerning a male who was vaccinated with an oral dose of Rotavirus vaccine. Subsequently the pt experienced  a low grade fever and crankiness. One week later, the pt was hospitalized for approx 48 hours due to vomiting, crankiness, and dehydration. The pt was discharged and was considered to be recovered. The physician also reported that the pts mother opted out of the second dose of Rotavirus vaccine. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Information has been received from a nurse concerning a 17 year old male with irritable bowel and asthma and no drug allergies who on 18-MAY-2010 at 5:00 PM was vaccinated intramuscularly into left deltoid with a dose of GARDASIL (Lot # 0670Y). Concomitant therapy included CYMBALTA. On 19-MAY-2010 at 03:00 AM the patient experienced vomiting and dry heaves. There was no lab diagnostics performed. Unspecified medical attention was sought. He had not recovered. Additional information has been requested.
"Took shingrix vaccine 3PM. She felt a little achy 6hrs later. At night she got up to pee and then got up and went to bathroom and felt warm sensation and couldn't focus and then she's on the ground. Head banging on the floor. Laid there for a few seconds and she got up and felt blood in back of her head. She then collapsed again. She then found her sister and then she went to village." Per Dr.
The day after the injection I got sick- nausea, headache, fever, rash on my cheeks and eyelids and nervous jitters. I thought it would pass, and all of it did except the rash on my face that has gone down a lot, but is still present. I called the doctor today and they said that I should report it to the CDC.
Patient developed cellulitis at the injection site, as well as fever, dizziness, nausea and vomiting. Patient went to ER to rule out heart attack. Patient was administered fluids and released. Patient recovered in couple of days.
I developed a rash on my neck that was very itchy, red, and bumpy about 30 hours following receiving my booster. I reached out to my doctor when the rash did not get better after 2 days. I have been treating with hydrocortizone
dizziness (acute), nausea, violent vomiting; sx began w/dizziness & nausea p/going to dinner (2 hrs later); progressed to vomiting violently; dizziness persisted until 10PM;
Pt waited 15 minutes after receiving the HPV GARDASIL vaccine and then was released. Pt went to car and left the facility then started to feel dizzy and had a syncope episode and then drove car off the road. Pt was transported to the ER after due to MVA and syncope.
47 YO MALE CONSCIOUS AND ALERT WITH A GCS OF 15 COMPLAINING OF FEELING NAUSEAUS. PT JUST RECIEVED HIS COVID 19 VACINATION. PT DENIED CHEST PAIN, SOB, V/D, HEAD NECK AND BACK PAIN, BLURRED VISION, DIZZINESS. PT HAD A PATENT AIRWAY WITH EQUAL CHEST RISE AND FALL. PT HAD NO NOTED DCAPBTLS, HEENT WAS UNREMARKABLE. PT VITALS WERE TAKEN AND RECORDED. PT WAS OFFERED TRANSPORT TO THE LOCAL HOSPITAL FOR FURTHER EVALUATION. PT REFUSED
This case was reported by a consumer via call center representative and described the occurrence of influenza in a adult male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, 1 day after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced influenza (serious criteria hospitalization), weakness (serious criteria hospitalization), difficulty breathing (serious criteria hospitalization), diarrhea (serious criteria hospitalization) and sleepiness (serious criteria hospitalization). On an unknown date, the outcome of the influenza, weakness, difficulty breathing, diarrhea and sleepiness were recovered/resolved. It was unknown if the reporter considered the influenza, weakness, difficulty breathing, diarrhea and sleepiness to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported but, it could be 60 or 61 years. The patient received the flu shot about 5 years ago before the date of reporting. The patient stated that, the day after he got the flu he was weak, had difficulty breathing, diarrhea and he was sleeping alot. He noted he was in the hospital for 6 days.  The patient has not gotten the flu shot since. The reporter did not consent to follow-up.
Pt arrived to ED due to having a seizure at work. She has had a runny nose, congestion, and a cough for the last week. She was found to be COVID positive. She was hypoxic and placed on 2L NC. Pt was admitted for pneumonia and seizure-like activity.
Covid Vaccine Arm, left arm, round red circle with bruise appearance in the center, tender and itchy at times. Noticed it on 03/13/21 and still visible with mentioned symptoms on 03/23/21.
Caller had Covid vaccine on 28Jan and tested positive for Covid today; Caller had Covid vaccine on 28Jan and tested positive for Covid today; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable consumer reported that a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 28Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had Covid vaccine on 28Jan2021 and tested positive for Covid today 30Jan2021. She is wondering what to do about 2nd dose and wonders if this is normal. The patient underwent lab tests and procedures which included COVID: positive on 30Jan2021. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
pt recv vax 9SEP97 & that evening devel vomiting & a temp 103;the next morning temp was 105.1;seen by MD 10SEP;T102.7;MD administered a phenergan suppository & an APAP suppository;felt was d/t viral illness;
blisters appeared above lips into nostrils & lower eyelid/duct. HA w/pain over/under eye. Treatment w/Acyclovir & eye ointment
Approximately 2 1/2 hrs after injection, small patch of hives bilat. inner biceps area.
I had the Pfizer vaccine, 1st and 2nd. The first one gave me the reaction most people say the 2nd one gives, although not quite as bad as what others have described. HOWEVER, the 2nd dose in my case, cause a severe flare-up of arthritic type symptoms in my joints, mostly both knees but no feverish reactions. When I say severe arthritic flare up, I mean debilitating to the point where it almost hurts too much to walk. I had the shot on a Friday, the arthritic pain began late that night and became worse on Saturday. It is now Monday and the pain has only subsided a little bit. It's still difficult to get up from a sitting position and to walk or stand for longer periods of time.
On 27th - headaches; body aches and lethargy; following day, 28th and 29th, I had stuffy nose and sore throat.Tylenol and Vitamin C - 1 gram a day;  I was tested for COVID on the 30th and was positive on the 1st. Quarantine until Jan 6 of January; second dose on 7th. My symptoms resolved before second dose. I had chills and body aches after second dose for 72 hours and then those resolved.
15 minutes after vaccination patient complained of arm tingling and numbness as she attempted to check out.  we asked her to stay a few more minutes to make sure she felt ok.  she sat back down and started coughing.  we asked her to take her mask off so she could breathe easier.  she started to wheeze.  we asked about previous allergies and she confirmed that she had anaphylaxis to 2 different vaccines (tetanus and MMR).  we monitored her breathing which became more labored.  she started to lose consciousness.  we administered an epi-pen in the right thigh.  within seconds her breathing relaxed.  we called for the emergency department.  they came and transported her to the ED for further evaluation.  she was treated with antihistamines and solu-medrol and then released.
Short of breath; Sneezing; Sneezing /a lot of mucus; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Lot number was not reported), dose number unknown via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medication was not reported. After 11 days of receiving the Pfizer vaccine on an unspecified date the patient experienced short of breath, sneezing continuously, and a lot of mucus only when patient only consumed ice cream, and this was repeated more than once, and it did not happen before. The clinical outcome of the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
redness at the injection site; 25 month old patient was vaccinated Kinrix; 4th dose of DTaP; the patient was suppose to received DTaP and Hib.; This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 2-year-old male patient who received DTPa-IPV (Kinrix) (batch number PP9L5, expiry date 16th October 2021) for prophylaxis.   On 10th June 2020, the patient received Kinrix (intramuscular) .5 ml. On 10th June 2020, 3 min after receiving Kinrix, the patient experienced injection site erythema, inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and wrong vaccine administered. On an unknown date, the outcome of the injection site erythema, inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and wrong vaccine administered were unknown.   It was unknown if the reporter considered the injection site erythema to be related to Kinrix.  Additional details were provided asa follows: The patient received dose of Kinrix in the left thigh. The medical assistant reported that, the 25 months old patient received dose of Kinrix, which led to inappropriate age at vaccine administration. The reporter stated that, the patient received 4th dose of DTaP, which led to inappropriate schedule vaccine administered. The reporter clarified that, the patient was suppose to received DTaP and Hib instead of Kinrix, which led to  wrong vaccine administered. The reporter stated that, 3 to 5 minuites after vaccination, the patient experienced redness at the injection site. No other details were provided.
NAILS TURNED ORANGE; This spontaneous report received from a pharmacist concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced nails turned orange. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nails turned orange. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard operating procedure as the case assessed as non-serious.
A 60 year old male received six weekly instillations of Tice BCG for bladder cancer. On 24Jun03 the pt informed the healthcare professional that his internist started him on Norvasc treatment for malignant hypertension that day. The pt's hypertension was found to be related to progression of his disease. Bladder cancer was impinging on the ureters and surgery (Cystectomy) was done.
Information has been received from a healthcare worker concerning a 58 year old female patient who was vaccinated with a dose of Pneumovax 23.  Subsequently, the patient developed severe redness and swelling in the arm around injection site.  Unspecified medical attention was sought.  Subsequently, the patient recovered.  Additional information has been requested.
sore arm; pregnancy; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (sore arm) and EXPOSURE DURING PREGNANCY (pregnancy) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 31-Mar-2021. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm) and EXPOSURE DURING PREGNANCY (pregnancy). On 08-Feb-2021, EXPOSURE DURING PREGNANCY (pregnancy) had resolved. At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: Internal review on 21-JUL-2021resulted in update of birth type and fetal outcome was updated.
Chronic Coughing, Hyperinflated Lungs,  Shortness of breath and Lung Scarring. Constant congestion and coughing phlegm. Was on antibiotics azithromycin, inhaler, and steroids.
Injection site redness, heat and soreness unlike the three previous doses. Began the morning following the vaccination and is still present approximately 18 hours since first noticed / 32 hours past vaccination.
Child was taken to ER on 06/12/2022 in the early morning hours for persistent itching of the entire body including inside the mouth, injection arm burning with swelling noted to the top of the arm, tightness of the throat, red blotchy areas noted to the face per mom. Mother began giving Benadryl on the day injections were given because child verbalized itching.  Mom reports the reaction just continued with time. She took the child to the ear when the child reported that her throat was tight.
high fever, projective vomiting, skin on back rough dry, itchy, lethargic;APAP & advil dec temp;no MD visit but mom c/o skin on back remaining rough& scaly;
When I walk it hurts; shoulders are in so much pain; This is a spontaneous report from a contactable consumer (patient). This report was not related to a study or programme. A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on an unspecified date (on Friday), as single dose for covid-19 immunisation. Medical history included Pain in joint, which the patient does have normally and auto immune condition. The patient concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: unknown) for covid-19 immunisation. On an unspecified date, after got up in the morning the patient felt it hurts when walk and the shoulders were in so much pain. Clinical course reported as, I got my second injection on Friday and I normally do have pain in my joint, I mean I do have auto immune condition but I got up this morning and I felt like I can hardly (Incomplete sentence), when I walk it hurts, my shoulders are in so much pain. All the events were reported as non-serious. The outcome of the events was unknown.   Information on the lot/batch number has been requested
initial report received from a health care professional on 08/30/2005. A 54 year old male patient received a subcutaneous injection of JE VAX vaccine, lot number EJN213A, site not reported, an intramuscular injection of Typhim VI vaccine, lot number W13443 in the left deltoid muscle on 7/8/2005. Then days later he developed large welty itchy areas like hives on both shoulders, arms and legs with right ankle swelling. The patient self medicated with antihistamines and recovered from this event. This patient experienced an adverse event on 7/4/2005 of red itchy rash following a previous injection of JE VAX on 7/1/2005 and that adverse event is detailed in case number 200501842.